Chinese pharmaceutical Sinovac Biotech Ltd which makes one of the vaccines against Covid 19 ... and will be delivering doses against Covid 19, Hepatitis A and influenza, according to Virginia ...

SINOVAC’s product portfolio includes vaccines against COVID-19, enterovirus 71 (EV71) infected hand-foot-mouth disease (HFMD), hepatitis A, varicella, influenza, poliomyelitis, pneumococcal ...

Sinovac is recognized for its research and development, manufacturing, and commercialization of vaccines for infectious diseases, including COVID-19, hepatitis A, and influenza, among others.

SINOVAC’s product portfolio includes vaccines against COVID-19, enterovirus 71 (EV71) infected hand-foot-mouth disease (HFMD), hepatitis A, varicella, influenza, poliomyelitis, pneumococcal ...

KUALA LUMPUR: Pharmaniaga Bhd has supplied 12 million doses of Sinovac COVID-19 vaccine to the government for the National COVID-19 Immunisation Programme (PICK) and the final batch will be ...

Sinovac vaccine: uses unreactive coronavirus particles ... Other common vaccines that use similar methods include the polio, hepatitis A and rabies vaccines. Multisystem inflammatory syndrome ...

SINOVAC’s product portfolio includes vaccines against COVID-19, enterovirus 71 (EV71) infected hand-foot-mouth disease (HFMD), hepatitis A, varicella, influenza, poliomyelitis, pneumococcal disease, ...

BEIJING, March 28, 2025--(BUSINESS WIRE)--Sinovac Biotech Ltd. (NASDAQ:SVA) ("SINOVAC" or the "Company"), a leading provider of biopharmaceutical products in China, today announced that its board ...